| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 30 Jan 2026 | 44 | 26% | 53% | 21% | 56% |
| 01 Jan 2025 - 30 Jun 2025 | 25 Jul 2025 | 47 | 16% | 54% | 30% | 81% |
| 01 Jul 2024 - 31 Dec 2024 | 17 Jan 2025 | 48 | 16% | 53% | 31% | 81% |
| 01 Jan 2024 - 30 Jun 2024 | 31 Jul 2024 | 49 | 14% | 55% | 31% | 80% |
| 01 Jul 2023 - 31 Dec 2023 | 22 Jan 2024 | 59 | 17% | 50% | 33% | 77% |
| 01 Jan 2023 - 30 Jun 2023 | 25 Jul 2023 | 70 | 14% | 43% | 43% | 83% |
| 01 Jul 2022 - 31 Dec 2022 | 31 Jan 2023 | 66 | 13% | 44% | 43% | 82% |
| 01 Jan 2022 - 30 Jun 2022 | 29 Jul 2022 | 70 | 9% | 42% | 49% | 86% |
| 01 Jul 2021 - 31 Dec 2021 | 24 Jan 2022 | 63 | 9% | 46% | 45% | 86% |
| 01 Jan 2021 - 30 Jun 2021 | 23 Jul 2021 | 57 | 11% | 50% | 39% | 83% |
| 01 Jul 2020 - 31 Dec 2020 | 15 Jan 2021 | 59 | 23% | 37% | 40% | 89% |
| 01 Jan 2020 - 30 Jun 2020 | 03 Aug 2020 | 63 | 20% | 36% | 44% | 76% |
| 01 Jan 2019 - 30 Jun 2019 | 11 Jul 2019 | 61 | 18% | 37% | 45% | 69% |
| 01 Jul 2018 - 31 Dec 2018 | 22 Jan 2019 | 65 | 12% | 42% | 46% | 72% |
| 01 Jan 2018 - 30 Jun 2018 | 23 Jul 2018 | 64 | 12% | 43% | 45% | 67% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
Payment terms negotiated with individual suppliers and range from 0 -90 days
Were there any changes to the standard payment terms in the reporting period?
Terms are negotiated with suppliers when contacts come up for renewal
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Invoices are recorded on ERP systems and blocked for payment until dispute resolved liaising with suppliers to try and resolve quickly.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Leica Biosystems Newcastle Limited is a UK-registered company forming part of the Leica Biosystems group, itself part of Danaher. The wider group develops and supplies anatomic and digital pathology equipment and consumables, covering the workflow from biopsy to diagnosis, including tissue processors, microtomes, cryostats, slide stainers, IHC and ISH instruments, digital slide scanners and related reagents and software. The group describes itself as a global leader in workflow solutions and automation for pathology laboratories, supporting cancer diagnostics research and companion diagnostic development. This entity represents the group's presence in Newcastle, contributing to the group's UK operations within this pathology and life sciences business rather than trading independently under its own separate product range.
Generated from the company's website and Companies House records. Sources: leicabiosystems.com · leicabiosystems.com